- IN₹1.30tn
- IN₹1.33tn
- IN₹68.13bn
India's Laurus Labs gains on Q1 profit surge
India's Laurus Labs falls; analysts flag weakness in upbeat Q4 results
Brief: Laurus Labs March-Quarter Consol Net Profit 2.34 Bln Rupees
Brief: Laurus Labs Receives EIR From USFDA For API Facility
Indian pharma stocks decline after Trump again threatens tariffs (updated)
Brief: Laurus Labs To Acquire 26% Stake In Kurnool Renewables
Brief: Laurus Labs Approves 833 Mln Rupees Investment In KRKA Pharma
Indian pharma stocks set for worst day in 2 years on Trump tariff woes
Indian pharma stocks gain after US resumes funding HIV treatments
Brief: Laurus Labs Clarifies Report "U.S. President Froze President's Emergency Plan For Aids Relief"
Brief: Laurus Labs Dec-Quarter Consol Net Profit 923 Mln Rupees
Brief: Laurus Labs Says US FDA Issued One Observation For Foreign Subsidiary Of Co
Brief: Laurus Labs Says Eight Roads Ventures, F-Prime Capital Invest Rupees 1.20 Billion In Laurus Bio
Brief: Laurus Labs Approves Investment Of 400 Mln Rupees In Laurus Bio
India's Glenmark Life eyes worst day ever after downbeat Q2 results
Brief: Laurus Labs Says Sept-Quarter Consol At Net Profit 198.4 Million Rupees
Brief: Laurus Labs Concludes USFDA Audit For API Manufacturing Facility At Hyderabad
Brief: Laurus Labs June-Quarter Consol Net Profit 125.1 Million Rupees
Brief: Willow Announces Product Development, Licensing Partnership With Laurus Labs